Stock 3320 CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company China Resources Pharmaceutical Group Limited

Equities

3320

HK0000311099

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:07 09/05/2024 BST 		5-day change 1st Jan Change
5.58 HKD +5.48% Intraday chart for China Resources Pharmaceutical Group Limited +10.06% +8.77%
04-24 China Resources Pharmaceutical Group Limited Announces Change of Company Secretary CI
04-18 China Resources Pharma Unit Issues 3 Billion Yuan Bonds MT

Business Summary

CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED is a Hongkong-based investment holding company. The Company, along with its subsidiaries, is principally engaged in the research and development, manufacturing, distribution and retail of pharmaceutical and other healthcare products. The Company mainly operates through three segments. Pharmaceutical Manufacturing segment is engaged in the research and development, manufacturing and sale of pharmaceutical and other healthcare products. Pharmaceutical Distribution segment is engaged in the provision of distribution solutions to pharmaceutical manufacturers and dispensers, such as hospitals and other medical institutions, distributors and retail pharmacies. Pharmaceutical Retail segment is involved in the operation of retail pharmacies in China and Hongkong.

Number of employees: 72,986

Sales per Business

HKD in Million2022Weight2023Weight Delta
Distribution
80.0 %
205,062 80.7 % 195,858 80.0 % -4.49%
Manufacturing
16.0 %
40,167 15.8 % 39,190 16.0 % -2.43%
Retail
3.9 %
8,837 3.5 % 9,579 3.9 % +8.40%
Others
0.0 %
41 0.0 % 76 0.0 % +87.21%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
99.4 %
253,501 99.8 % 243,114 99.4 % -4.10%
Others
0.6 %
-- 1,590 0.6 % -

Managers

Managers TitleAgeSince
Xiao Song Bai CEO
 Chief Executive Officer 52 13/01/22
Rong Hui Deng DFI
 Director of Finance/CFO 46 12/06/23
Yue Wei Han CHM
 Chairman 56 21/10/19

Members of the board

Members of the board TitleAgeSince
Rui Fang Jiao BRD
 Director/Board Member 47 13/01/22
Ting Mei Fu BRD
 Director/Board Member 57 31/05/16
Ke Jian Zhang BRD
 Director/Board Member 68 19/06/16
Kin Fun Kwok BRD
 Director/Board Member 75 19/06/16
Ran Tao BRD
 Director/Board Member 59 06/09/21
Mo Han Shing BRD
 Director/Board Member 68 06/08/17
Yue Wei Han CHM
 Chairman 56 21/10/19
Rong Hui Deng DFI
 Director of Finance/CFO 46 12/06/23
Bo Hou BRD
 Director/Board Member 60 25/03/21
Xiao Song Bai CEO
 Chief Executive Officer 52 13/01/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 6,282,510,461 1,755,919,500 ( 27.95 %) 0 27.95 %

Shareholders

NameEquities%Valuation
China State-Owned Assets Supervision & Admn Commission
53.05 %
3,333,185,612 53.05 % 2 129 M $
City of Beijing
17.43 %
1,094,800,000 17.43 % 699 M $
Beijing Equity Investment Development Fund Cayman Ii LP
2.586 %
162,438,849 2.586 % 104 M $
Bosera Asset Management Co., Ltd.
0.2340 %
14,698,000 0.2340 % 9 M $
Zhong Ou Asset Management Co., Ltd
0.2036 %
12,790,000 0.2036 % 8 M $
Principal Global Investors (Hong Kong) Ltd.
0.1977 %
12,422,500 0.1977 % 8 M $
Robeco Hong Kong Ltd.
0.1512 %
9,499,500 0.1512 % 6 M $
Fullgoal Fund Management Co., Ltd.
0.1404 %
8,820,000 0.1404 % 6 M $
First Seafront Fund Management Co., Ltd.
0.1019 %
6,401,000 0.1019 % 4 M $
Research Affiliates LLC
0.0931 %
5,847,000 0.0931 % 4 M $

Holdings

NameEquities%Valuation
CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.
63.63%
 622,569,632 63.63% 4,469,782,253 $
CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.
61.09%
 625,795,624 61.09% 1,789,731,679 $
DONG-E-E-JIAO CO.,LTD.
32.01%
 209,286,847 32.01% 1,781,447,549 $
JIANG ZHONG PHARMACEUTICAL CO.,LTD
43.46%
 271,071,486 43.46% 926,394,936 $
CHINA RESOURCES BOYA BIO-PHARMACEUTICAL GROUP CO.,LTD
100.00%
 78,308,575 100.00% 311,177,917 $
TYCOON GROUP HOLDINGS LIMITED
18.99%
 151,895,000 18.99% 80,931,175 $

Company contact information

China Resources Pharmaceutical Group Ltd.

41/F, China Resources Building Room 4104-05

, Hong Kong

+852 2593 8991

http://www.crpharm.com
address China Resources Pharmaceutical Group Limited(3320)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for China Resources Pharmaceutical Group Limited

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
5.29 HKD
Average target price
7.424 HKD
Spread / Average Target
+40.35%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED Stock China Resources Pharmaceutical Group Limited
+8.77% 4.25B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.95% 698B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.97% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.83% 328B
ABBVIE INC. Stock AbbVie Inc.
+3.54% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.08% 238B
NOVARTIS AG Stock Novartis AG
+6.68% 203B
ROCHE HOLDING AG Stock Roche Holding AG
-9.08% 198B
AMGEN INC. Stock Amgen Inc.
+6.70% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 3320 Stock
  4. Company China Resources Pharmaceutical Group Limited